Compounds and methods for CD73 modulation and indications therefor
US-12509444-B2 · Dec 30, 2025 · US
This page is not indexed by search engines while we improve data quality.
Buell John patents
Buell John is listed as an inventor on 28 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Buell John |
| Total patents | 28 |
| First publication | May 14, 2015 |
| Latest publication | Dec 30, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereof
US-2024400587-A1 · Dec 5, 2024 · US
Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereof
US-12091426-B2 · Sep 17, 2024 · US
Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereof
US-2024025923-A1 · Jan 25, 2024 · US
Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereof
US-2024018162-A1 · Jan 18, 2024 · US
Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereof
US-11739101-B2 · Aug 29, 2023 · US
Compounds and methods for kras modulation and indications therefor
US-2023081426-A1 · Mar 16, 2023 · US
Compounds and methods for cd73 modulation and indications therefor
US-2022144805-A1 · May 12, 2022 · US
Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereof
US-2021355140-A1 · Nov 18, 2021 · US
Compounds and methods for IDO and TDO modulation, and indications therefor
US-11149011-B2 · Oct 19, 2021 · US
Recent patents
Latest publications not already listed above.
COMPOUNDS AND METHODS FOR EP300 or CBP MODULATION AND INDICATIONS THEREFOR
US-2021315872-A1 · Oct 14, 2021 · US
Compounds and methods for cd73 modulation and indications therefor
US-2021198239-A1 · Jul 1, 2021 · US
Compounds and methods for CDK8 modulation and indications therefor
US-10703757-B2 · Jul 7, 2020 · US
Heterocyclic compounds and uses thereof
US-10519177-B2 · Dec 31, 2019 · US
Compounds and methods for IDO and TDO modulation, and indications therefor
US-10508085-B2 · Dec 17, 2019 · US
Compounds and methods for ido and tdo modulation, and indications therefor
US-2019300487-A1 · Oct 3, 2019 · US
Compounds and methods for kinase modulation, and indications therefor
US-10227357-B2 · Mar 12, 2019 · US
Compounds and methods for kinase modulation, and indications therefor
US-10160755-B2 · Dec 25, 2018 · US
Compounds and methods for kinase modulation, and indications therefor
US-10160747-B2 · Dec 25, 2018 · US
Compounds and methods for cdk8 modulation and indications therefor
US-2018215763-A1 · Aug 2, 2018 · US
Compounds and methods for ido and tdo modulation and indications therefor
US-2018099939-A1 · Apr 12, 2018 · US
Heterocyclic compounds and uses thereof
US-2017320899-A1 · Nov 9, 2017 · US
Compounds and methods for kinase modulation, and indications therefor
US-9771369-B2 · Sep 26, 2017 · US
Compounds and methods for kinase modulation, and indications therefor
US-2017267660-A1 · Sep 21, 2017 · US
Heterocyclic compounds and uses thereof
US-9718847-B2 · Aug 1, 2017 · US
Compounds and methods for kinase modulation, and indications therefor
US-2016326162-A1 · Nov 10, 2016 · US
Compounds and methods for kinase modulation, and indications therefor
US-2015284397-A1 · Oct 8, 2015 · US
Heterocyclic compounds and uses thereof
US-2015133400-A1 · May 14, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Plexxikon Inc | 22 |
| Nurix Therapeutics Inc | 6 |
| Gilead Sciences Inc | 6 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 22 |
| A61K31/506 | 14 |
| C07D519/00 | 14 |
| C07D471/04 | 14 |
| A61P37/02 | 14 |